• 1. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids and derivatives Piperidinecarboxylic acids

Tert-butyl 3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate (CAS No. 1217710-80-9): An Overview

Tert-butyl 3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate (CAS No. 1217710-80-9) is a versatile and widely studied compound in the field of medicinal chemistry and pharmaceutical research. This compound, also known as Boc₂-protected piperidine, plays a crucial role in the synthesis of various biologically active molecules, particularly in the development of central nervous system (CNS) drugs and enzyme inhibitors.

The chemical structure of Tert-butyl 3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate consists of a piperidine ring with two tert-butoxycarbonyl (Boc) protecting groups. The Boc groups are essential for controlling the reactivity and stability of the amino functionalities during synthetic processes. This compound is often used as an intermediate in the synthesis of complex molecules, where its protected amine groups can be selectively deprotected at specific stages of the synthesis to introduce functional groups or linkages.

Recent studies have highlighted the importance of Tert-butyl 3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate in the development of novel therapeutic agents. For instance, a study published in the Journal of Medicinal Chemistry demonstrated that this compound can be used to synthesize potent inhibitors of protein kinases, which are key targets in cancer therapy. The Boc protection strategy allows for precise control over the reactivity and selectivity of the amino groups, enabling the synthesis of highly specific inhibitors with improved pharmacological properties.

In addition to its applications in cancer research, Tert-butyl 3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate has also been explored in the context of neurodegenerative diseases. A study published in Chemical Biology & Drug Design reported the use of this compound as a key intermediate in the synthesis of small molecules that modulate G protein-coupled receptors (GPCRs), which are implicated in conditions such as Alzheimer's disease and Parkinson's disease. The ability to selectively deprotect and functionalize the amino groups provides a powerful tool for optimizing the pharmacological profiles of these molecules.

The synthetic versatility of Tert-butyl 3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate is further exemplified by its use in combinatorial chemistry and high-throughput screening. Researchers have utilized this compound to generate libraries of structurally diverse molecules, which can be screened for a wide range of biological activities. This approach has led to the discovery of several lead compounds with promising therapeutic potential, including inhibitors of enzymes involved in metabolic disorders and anti-inflammatory agents.

The physical and chemical properties of Tert-butyl 3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate make it an ideal candidate for various synthetic transformations. It is stable under standard laboratory conditions and can be easily purified by standard techniques such as column chromatography. The compound is also compatible with a wide range of solvents and reagents, making it suitable for use in both small-scale laboratory settings and large-scale industrial processes.

In conclusion, Tert-butyl 3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate (CAS No. 1217710-80-9) is a valuable intermediate in medicinal chemistry and pharmaceutical research. Its unique chemical structure and synthetic versatility have made it an essential tool for the development of novel therapeutic agents targeting a variety of diseases. Ongoing research continues to explore new applications and optimizations, further solidifying its importance in the field.

• 172478-01-2(tert-butyl N-methyl-N-(piperidin-3-yl)carbamate)
• 203941-94-0(tert-butyl (3R)-3-(methylamino)piperidine-1-carboxylate)
• 1000576-83-9(tert-Butyl 3-(dimethylamino)piperidine-1-carboxylate)
• 309962-63-8(tert-butyl N-methyl-N-[(3S)-piperidin-3-yl]carbamate)
• 370069-31-1(Tert-butyl 2-(aminomethyl)piperidine-1-carboxylate)
• 1061682-78-7(1-Piperidinecarboxylicacid, 3-(dimethylamino)-, 1,1-dimethylethyl ester, (3R)-)
• 392331-89-4(Tert-Butyl 3-(methylamino)piperidine-1-carboxylate)
• 309962-67-2(tert-butyl N-methyl-N-[(3R)-piperidin-3-yl]carbamate)
• 475105-35-2(tert-butyl (2S)-2-(aminomethyl)piperidine-1-carboxylate)
• 502633-95-6(1-Piperidinecarboxylicacid, 2-[(dimethylamino)methyl]-, 1,1-dimethylethyl ester, (2S)-)